SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors-Reference-Cited by-同舟云学术

SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors

Published:2012-12 Issue: Volume:76 Page:91-101
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

Milan Enrico,Lazzari Chiara,Anand Santosh,Floriani Irene,Torri Valter,Sorlini Cristina,Gregorc Vanesa,Bachi Angela

Funder

AIRC

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference34 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2008

2. Changing trends in the distribution of the histologic types of lung cancer: a review of 4439 cases;Wahbah;Ann Diagn Pathol,2007

3. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

4. Erlotinib versus chemotherapy as first line treatment for patients with advanced EGFR mutation positive non small cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open label, randomised, phase III trial;Zhou;Lancet Oncol,2011

5. Erlotinib in previously treated non small cell lung cancer;Shepherd;N Engl J Med,2005

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between small-cell lung cancer serum protein/peptides determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemotherapy efficacy;Clinical Proteomics;2024-05-19

2. Contribution of crosstalk of mesothelial and tumoral epithelial cells in pleural metastasis of lung cancer;Translational Lung Cancer Research;2024-05

3. Development of a breast cancer prognostic model based on vesicle-mediated transport-related genes to predict immune landscape and clinical drug therapy;Human Molecular Genetics;2023-12-21

4. Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance;Journal of Mass Spectrometry and Advances in the Clinical Lab;2023-11

5. Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment;Journal of Cancer Research and Clinical Oncology;2023-09-14